|
CA2667894A1
(en)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
|
JOP20080381B1
(ar)
*
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
|
EP4248976B1
(en)
*
|
2007-08-23 |
2026-04-22 |
Amgen Inc. |
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
|
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
|
US9089522B2
(en)
*
|
2008-05-22 |
2015-07-28 |
Merck Sharp & Dohme Corp. |
Method of reducing total cholesterol level by administering matrilin-2 polypeptide
|
|
US8206943B1
(en)
|
2008-06-30 |
2012-06-26 |
Schering Corporation |
Assay for PCSK9 inhibitors
|
|
AU2015200427B2
(en)
*
|
2008-09-12 |
2016-11-10 |
Pfizer Inc. |
PCSK9 antagonists
|
|
AU2013200743B2
(en)
*
|
2008-09-12 |
2014-10-30 |
Pfizer Inc. |
PCSK9 antagonists
|
|
TWI445716B
(zh)
|
2008-09-12 |
2014-07-21 |
Rinat Neuroscience Corp |
Ｐｃｓｋ９拮抗劑類
|
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
|
US20130064834A1
(en)
|
2008-12-15 |
2013-03-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia using antibodies to pcsk9
|
|
US8357371B2
(en)
|
2008-12-15 |
2013-01-22 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia using antibodies to PCSK9
|
|
KR101660578B1
(ko)
*
|
2009-09-03 |
2016-09-27 |
화이자 백신스 엘엘씨 |
Ｐｃｓｋ９ 백신
|
|
WO2011053743A1
(en)
*
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Pcsk9 immunoassay
|
|
AU2010313324A1
(en)
*
|
2009-10-30 |
2012-04-12 |
Merck Sharp & Dohme Corp. |
AX213 and AX132 PCSK9 antagonists and variants
|
|
CA2777698A1
(en)
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Ax1 and ax189 pcsk9 antagonists and variants
|
|
GB201005005D0
(en)
*
|
2010-03-25 |
2010-05-12 |
Angeletti P Ist Richerche Bio |
New vaccine
|
|
EP2450382A1
(de)
*
|
2010-11-04 |
2012-05-09 |
Affiris AG |
Immunogenes Peptid
|
|
US8771696B2
(en)
|
2010-11-23 |
2014-07-08 |
Regeneron Pharmaceuticals, Inc. |
Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor
|
|
JO3756B1
(ar)
*
|
2010-11-23 |
2021-01-31 |
Regeneron Pharma |
اجسام مضادة بشرية لمستقبلات الجلوكاجون
|
|
CN103261230A
(zh)
*
|
2010-12-22 |
2013-08-21 |
霍夫曼-拉罗奇有限公司 |
抗pcsk9抗体及使用方法
|
|
CA2825778A1
(en)
*
|
2011-01-28 |
2012-08-02 |
Sanofi |
Pharmaceutical compositions comprising human antibodies to pcsk9
|
|
MX2013009258A
(es)
*
|
2011-02-11 |
2013-10-17 |
Novartis Ag |
Antagonistas de pcsk9.
|
|
AR088782A1
(es)
*
|
2011-04-29 |
2014-07-10 |
Sanofi Sa |
Sistemas de ensayo y metodos para identificar y caracterizar farmacos hipolipemiantes
|
|
JOP20200043A1
(ar)
*
|
2011-05-10 |
2017-06-16 |
Amgen Inc |
طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
|
|
AR087305A1
(es)
|
2011-07-28 |
2014-03-12 |
Regeneron Pharma |
Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit
|
|
ES2773111T3
(es)
|
2011-09-16 |
2020-07-09 |
Regeneron Pharma |
Inhibidor de la proproteína convertasa subtilisina/kexina 9 (PCSK9) para su uso en la reducción de los niveles de lipoproteína (a)
|
|
AR087715A1
(es)
|
2011-09-16 |
2014-04-09 |
Lilly Co Eli |
Anticuerpos anti pcsk9 y usos de los mismos
|
|
WO2013086443A1
(en)
|
2011-12-08 |
2013-06-13 |
Amgen Inc. |
Agonistic human lcat antigen binding proteins and their use in therapy
|
|
CN104169304A
(zh)
*
|
2011-12-20 |
2014-11-26 |
阿达拉塔合伙有限公司 |
作为pcsk9抑制剂的单域抗体
|
|
EA039663B1
(ru)
*
|
2012-05-03 |
2022-02-24 |
Амген Инк. |
Применение антитела против pcsk9 для снижения сывороточного холестерина лпнп и лечения связанных с холестерином расстройств
|
|
US9255154B2
(en)
*
|
2012-05-08 |
2016-02-09 |
Alderbio Holdings, Llc |
Anti-PCSK9 antibodies and use thereof
|
|
EP2667197B1
(en)
|
2012-05-25 |
2015-09-16 |
Zora Biosciences OY |
Sensitive efficacy and specificity biomarkers for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition
|
|
AR091462A1
(es)
|
2012-06-15 |
2015-02-04 |
Genentech Inc |
Anticuerpos anti-pcsk9, formulaciones, dosificacion y metodos de uso
|
|
NZ704771A
(en)
|
2012-08-13 |
2018-02-23 |
Regeneron Pharma |
Anti-pcsk9 antibodies with ph-dependent binding characteristics
|
|
EP2703009A1
(en)
*
|
2012-08-31 |
2014-03-05 |
Sanofi |
Combination treatments involving antibodies to human PCSK9
|
|
JP2015535464A
(ja)
|
2012-11-21 |
2015-12-14 |
アムジエン・インコーポレーテツド |
薬剤送達装置
|
|
WO2014160088A2
(en)
*
|
2013-03-14 |
2014-10-02 |
Rhode Island Hospital, A Lifespan-Partner |
Treating hepatitis b virus infections
|
|
US10492990B2
(en)
|
2013-03-15 |
2019-12-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
AU2014235430A1
(en)
*
|
2013-03-15 |
2015-09-24 |
Amgen Inc. |
Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9 (PCSK9)
|
|
TWI592183B
(zh)
|
2013-03-15 |
2017-07-21 |
安美基公司 |
本體輪廓可調適之自動注射器裝置
|
|
US10092703B2
(en)
|
2013-03-15 |
2018-10-09 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
ES2853748T3
(es)
|
2013-03-22 |
2021-09-17 |
Amgen Inc |
Inyector y método de montaje
|
|
US10111953B2
(en)
|
2013-05-30 |
2018-10-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
|
|
TW201534324A
(zh)
|
2013-06-07 |
2015-09-16 |
Sanofi Sa |
藉由投與ｐｃｓｋ９抑制劑抑制動脈粥狀硬化的方法
|
|
JP6267792B2
(ja)
*
|
2013-06-28 |
2018-01-24 |
アムジエン・インコーポレーテツド |
ホモ接合性家族性高コレステロール血症の治療方法
|
|
WO2015017791A1
(en)
*
|
2013-08-01 |
2015-02-05 |
Atherotech, Inc. |
Pcsk9 function assay
|
|
CN105612179B
(zh)
*
|
2013-10-09 |
2020-01-21 |
研究发展基金会 |
单克隆olfml-3抗体及其用途
|
|
MX2016005315A
(es)
|
2013-10-24 |
2016-08-11 |
Amgen Inc |
Sistema de administracion de farmacos con control sensible a la temperatura.
|
|
EP3060275B1
(en)
|
2013-10-24 |
2019-07-03 |
Amgen Inc. |
Injector and method of assembly
|
|
US10428157B2
(en)
|
2013-11-12 |
2019-10-01 |
Sanofi Biotechnology |
Dosing regimens for use with PCSK9 inhibitors
|
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
|
US8986694B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Targeting human nav1.7 variants for treatment of pain
|
|
US9034332B1
(en)
|
2014-07-15 |
2015-05-19 |
Kymab Limited |
Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
|
|
US9067998B1
(en)
|
2014-07-15 |
2015-06-30 |
Kymab Limited |
Targeting PD-1 variants for treatment of cancer
|
|
US9023359B1
(en)
|
2014-07-15 |
2015-05-05 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
|
US9045548B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment
|
|
US8992927B1
(en)
|
2014-07-15 |
2015-03-31 |
Kymab Limited |
Targeting human NAV1.7 variants for treatment of pain
|
|
US9051378B1
(en)
|
2014-07-15 |
2015-06-09 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
|
DE202014010499U1
(de)
|
2013-12-17 |
2015-10-20 |
Kymab Limited |
Targeting von humaner PCSK9 zur Cholesterinbehandlung
|
|
US8883157B1
(en)
|
2013-12-17 |
2014-11-11 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
|
US9017678B1
(en)
|
2014-07-15 |
2015-04-28 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
|
US9045545B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision medicine by targeting PD-L1 variants for treatment of cancer
|
|
US8986691B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
|
US8945560B1
(en)
|
2014-07-15 |
2015-02-03 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
|
US8980273B1
(en)
|
2014-07-15 |
2015-03-17 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
|
SG11201609219QA
(en)
|
2014-05-07 |
2016-12-29 |
Amgen Inc |
Autoinjector with shock reducing elements
|
|
US20170103186A1
(en)
|
2014-06-03 |
2017-04-13 |
Amgen Inc. |
Systems and methods for supporting patient use of a drug delivery device
|
|
EP3332790A1
(en)
|
2014-07-15 |
2018-06-13 |
Kymab Limited |
Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
|
|
DE202015009006U1
(de)
|
2014-07-15 |
2016-08-19 |
Kymab Limited |
Targeting von humaner PCSK9 zur Cholesterinbehandlung
|
|
US9139648B1
(en)
|
2014-07-15 |
2015-09-22 |
Kymab Limited |
Precision medicine by targeting human NAV1.9 variants for treatment of pain
|
|
US9150660B1
(en)
|
2014-07-15 |
2015-10-06 |
Kymab Limited |
Precision Medicine by targeting human NAV1.8 variants for treatment of pain
|
|
EP4328245A3
(en)
|
2014-07-15 |
2024-06-05 |
Kymab Ltd. |
Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
|
|
KR20230074283A
(ko)
|
2014-07-16 |
2023-05-26 |
사노피 바이오테크놀로지 |
이형접합성 가족성 고콜레스테롤혈증(heFH) 환자의 치료방법
|
|
WO2016023916A1
(en)
|
2014-08-12 |
2016-02-18 |
Kymab Limited |
Treatment of disease using ligand binding to targets of interest
|
|
CN104558199B
(zh)
*
|
2014-09-05 |
2018-07-06 |
成都康弘生物科技有限公司 |
一种治疗高胆固醇血症的融合蛋白制备及其用途
|
|
EP3194441A1
(en)
|
2014-09-16 |
2017-07-26 |
Regeneron Pharmaceuticals, Inc. |
Anti-glucagon antibodies and uses thereof
|
|
ES3056224T3
(en)
|
2014-10-14 |
2026-02-19 |
Amgen Inc |
Drug injection device with visual and audible indicators
|
|
WO2016071701A1
(en)
|
2014-11-07 |
2016-05-12 |
Kymab Limited |
Treatment of disease using ligand binding to targets of interest
|
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
EP3689394A1
(en)
|
2014-12-19 |
2020-08-05 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
US10583245B2
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
ES2905870T3
(es)
|
2015-02-27 |
2022-04-12 |
Amgen Inc |
Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja
|
|
US9139653B1
(en)
|
2015-04-30 |
2015-09-22 |
Kymab Limited |
Anti-human OX40L antibodies and methods of treatment
|
|
EP3271405A1
(en)
*
|
2015-03-20 |
2018-01-24 |
Aarhus Universitet |
Inhibitors of pcsk9 for treatment of lipoprotein metabolism disorders
|
|
EA201890519A1
(ru)
|
2015-08-18 |
2018-07-31 |
Ридженерон Фармасьютикалз, Инк. |
Ингибирующие антитела против pcsk9 для лечения пациентов с гиперлипидемией, подвергающихся аферезу липопротеинов
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
CN106589127A
(zh)
*
|
2015-10-16 |
2017-04-26 |
钜川生物医药 |
一种pcsk9抗体及其制备方法和应用
|
|
CN105214087B
(zh)
*
|
2015-10-29 |
2017-12-26 |
陈敏 |
Pcsk9单克隆抗体在制备治疗炎症免疫性疾病药物中的应用
|
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
WO2017160799A1
(en)
|
2016-03-15 |
2017-09-21 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
MX2018013616A
(es)
|
2016-05-13 |
2019-02-21 |
Amgen Inc |
Montaje de cubierta protectora de vial.
|
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
ES3066292T3
(en)
|
2016-06-03 |
2026-05-12 |
Amgen Inc |
Impact testing apparatuses and methods for drug delivery devices
|
|
KR102379464B1
(ko)
|
2016-06-20 |
2022-03-29 |
키맵 리미티드 |
항-pd-l1 항체
|
|
EP3478342B1
(en)
|
2016-07-01 |
2025-03-12 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018052789A1
(en)
*
|
2016-09-08 |
2018-03-22 |
Pcm Targetech, Llc |
Monoclonal antibodies specific to the plexin-semaphorin-integrin (psi) domain of ron for drug delivery and its application in cancer therapy
|
|
WO2018075792A1
(en)
|
2016-10-20 |
2018-04-26 |
Regeneron Pharmaceuticals, Inc. |
Methods of lowering blood glucose levels
|
|
EP3532127B1
(en)
|
2016-10-25 |
2026-04-08 |
Amgen Inc. |
On-body injector
|
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
|
WO2018136398A1
(en)
|
2017-01-17 |
2018-07-26 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
AU2018220538B2
(en)
|
2017-02-17 |
2023-12-14 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
WO2018165143A1
(en)
|
2017-03-06 |
2018-09-13 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
|
KR102627069B1
(ko)
|
2017-03-07 |
2024-01-18 |
암겐 인코포레이티드 |
과압에 의한 바늘 삽입
|
|
SG11201908062QA
(en)
|
2017-03-09 |
2019-09-27 |
Amgen Inc |
Insertion mechanism for drug delivery device
|
|
MX2019011416A
(es)
|
2017-03-28 |
2019-11-01 |
Amgen Inc |
Sistema y metodo para conjunto de jeringa y vastago de embolo.
|
|
CA3066399A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Torque driven drug delivery device
|
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
MA49447A
(fr)
|
2017-06-22 |
2020-04-29 |
Amgen Inc |
Réduction des impacts/chocs d'activation d'un dispositif
|
|
JP7475860B2
(ja)
|
2017-06-23 |
2024-04-30 |
アムジエン・インコーポレーテツド |
スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス
|
|
JP7408398B2
(ja)
|
2017-07-14 |
2024-01-05 |
アムジエン・インコーポレーテツド |
二重ねじりばねシステムを有する針挿入後退システム
|
|
JP7649105B2
(ja)
|
2017-07-21 |
2025-03-19 |
アムジエン・インコーポレーテツド |
薬物容器のためのガス透過性シーリング部材及び組立方法
|
|
EP3658206A1
(en)
|
2017-07-25 |
2020-06-03 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
|
WO2019022951A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSEMBLY METHOD THEREOF
|
|
US12318593B2
(en)
|
2017-08-09 |
2025-06-03 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
|
EP3668567B1
(en)
|
2017-08-18 |
2026-02-18 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
EP4257164A3
(en)
|
2017-10-06 |
2024-01-17 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
|
MA50348A
(fr)
|
2017-10-09 |
2020-08-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
|
|
ES3069718T3
(en)
|
2017-11-03 |
2026-06-10 |
Amgen Inc |
System and approaches for sterilizing a drug delivery device
|
|
CA3079197A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
|
MA50569A
(fr)
|
2017-11-06 |
2020-09-16 |
Amgen Inc |
Ensembles de remplissage-finition et procédés associés
|
|
IL319987A
(en)
|
2017-11-10 |
2025-06-01 |
Amgen Inc |
Plungers for drug delivery devices
|
|
JP7747438B2
(ja)
|
2017-11-16 |
2025-10-01 |
アムジエン・インコーポレーテツド |
失速及び終点検出を有するオートインジェクタ
|
|
AU2018368340B2
(en)
|
2017-11-16 |
2024-03-07 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
|
CN109897110B
(zh)
*
|
2017-12-08 |
2022-05-17 |
深圳华大生命科学研究院 |
纳米抗体及其制备方法
|
|
JP6639463B2
(ja)
*
|
2017-12-21 |
2020-02-05 |
アムジエン・インコーポレーテツド |
ホモ接合性家族性高コレステロール血症の治療方法
|
|
US20210324067A9
(en)
*
|
2018-03-09 |
2021-10-21 |
The Brigham And Women's Hospital, Inc. |
Combination therapy for cardiovascular diseases
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
CN112469454B
(zh)
|
2018-07-24 |
2024-01-26 |
安进公司 |
用于施用药物的输送装置
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
MA53320A
(fr)
|
2018-07-31 |
2021-11-03 |
Amgen Inc |
Ensemble de trajet de fluide pour dispositif d'administration de médicament
|
|
CA3106452A1
(en)
|
2018-09-24 |
2020-04-02 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
US12042642B2
(en)
|
2018-09-28 |
2024-07-23 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
|
WO2020072577A1
(en)
|
2018-10-02 |
2020-04-09 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
JP7547325B2
(ja)
|
2018-10-05 |
2024-09-09 |
アムジエン・インコーポレーテツド |
投薬量インジケータを有する薬物送達デバイス
|
|
JP7719714B2
(ja)
|
2018-10-15 |
2025-08-06 |
アムジエン・インコーポレーテツド |
ダンピング機構を有する薬物送達装置
|
|
MA53913A
(fr)
|
2018-10-15 |
2022-01-19 |
Amgen Inc |
Procédé d'assemblage de plate-forme pour dispositif d'administration de médicament
|
|
MA54057A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
|
|
WO2020091956A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
WO2020150473A2
(en)
|
2019-01-18 |
2020-07-23 |
Dogma Therapeutics, Inc. |
Pcsk9 inhibitors and methods of use thereof
|
|
BR112021013924A2
(pt)
*
|
2019-01-18 |
2021-09-21 |
Astrazeneca Ab |
Inibidores de pcsk9 e métodos de uso do mesmo
|
|
EP3958934B1
(en)
|
2019-04-24 |
2025-04-09 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
US20220273887A1
(en)
|
2019-08-23 |
2022-09-01 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
JP2023501745A
(ja)
*
|
2019-11-18 |
2023-01-18 |
エーディー ファーマシューティカルズ カンパニー，リミティド |
抗ｐｃｓｋ９抗体及びその使用
|
|
KR20210158693A
(ko)
*
|
2020-06-24 |
2021-12-31 |
바이오스트림테크놀러지스(주) |
항 ｐｃｓｋ９ 항체 및 이의 용도
|
|
BR112023024278A2
(pt)
|
2021-05-21 |
2024-01-30 |
Amgen Inc |
Método de otimizar uma receita de enchimento para um recipiente de fármacos
|
|
MX2024001877A
(es)
|
2021-08-10 |
2024-02-28 |
Kymab Ltd |
Tratamiento de dermatitis atopica.
|
|
EP4467563A1
(en)
*
|
2023-05-23 |
2024-11-27 |
JLP Health GmbH |
Ldlr derived polypeptides for anti-viral uses
|
|
WO2024240848A1
(en)
*
|
2023-05-23 |
2024-11-28 |
Jlp Health Gmbh |
Ldlr derived polypeptides for anti-viral uses
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|
|
CN119080877B
(zh)
*
|
2024-10-11 |
2025-09-23 |
完美（广东）日用品有限公司 |
一种低聚肽及其在制备减脂制品中的应用
|